KR101106053B1 - Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof - Google Patents
Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof Download PDFInfo
- Publication number
- KR101106053B1 KR101106053B1 KR1020110015226A KR20110015226A KR101106053B1 KR 101106053 B1 KR101106053 B1 KR 101106053B1 KR 1020110015226 A KR1020110015226 A KR 1020110015226A KR 20110015226 A KR20110015226 A KR 20110015226A KR 101106053 B1 KR101106053 B1 KR 101106053B1
- Authority
- KR
- South Korea
- Prior art keywords
- plant
- leaf
- extract
- antimicrobial activity
- haemopillus
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 244000000010 microbial pathogen Species 0.000 title abstract description 8
- 230000000845 anti-microbial effect Effects 0.000 title description 66
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 15
- 230000003115 biocidal effect Effects 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 56
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 35
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 29
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 27
- 239000004571 lime Substances 0.000 claims description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- 241001453380 Burkholderia Species 0.000 claims description 9
- 239000000401 methanolic extract Substances 0.000 claims description 8
- 208000023504 respiratory system disease Diseases 0.000 claims description 7
- 239000002026 chloroform extract Substances 0.000 claims description 3
- 239000002035 hexane extract Substances 0.000 claims description 3
- 241000190410 Citrus longispina Species 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 241000606831 Histophilus somni Species 0.000 claims 2
- 244000089742 Citrus aurantifolia Species 0.000 description 51
- 241000196324 Embryophyta Species 0.000 description 47
- 244000163122 Curcuma domestica Species 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 235000003392 Curcuma domestica Nutrition 0.000 description 26
- 241000219782 Sesbania Species 0.000 description 23
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 239000002904 solvent Substances 0.000 description 20
- 239000004615 ingredient Substances 0.000 description 18
- 244000144972 livestock Species 0.000 description 17
- 239000000419 plant extract Substances 0.000 description 16
- 238000011156 evaluation Methods 0.000 description 15
- 240000001724 Piper sarmentosum Species 0.000 description 14
- 235000015392 Sesbania grandiflora Nutrition 0.000 description 13
- 241000193468 Clostridium perfringens Species 0.000 description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 12
- 229940088710 antibiotic agent Drugs 0.000 description 12
- 235000003373 curcuma longa Nutrition 0.000 description 12
- 235000013976 turmeric Nutrition 0.000 description 12
- 241001508395 Burkholderia sp. Species 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 11
- 241000588912 Pantoea agglomerans Species 0.000 description 11
- 230000003078 antioxidant effect Effects 0.000 description 11
- 230000000688 enterotoxigenic effect Effects 0.000 description 11
- 244000052616 bacterial pathogen Species 0.000 description 10
- 244000052769 pathogen Species 0.000 description 10
- 244000281594 Cassia siamea Species 0.000 description 9
- 235000006715 Cassia siamea Nutrition 0.000 description 9
- 230000036961 partial effect Effects 0.000 description 9
- 244000060011 Cocos nucifera Species 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 235000008898 Morinda citrifolia Nutrition 0.000 description 8
- 244000131360 Morinda citrifolia Species 0.000 description 8
- 241000207199 Citrus Species 0.000 description 7
- 235000013162 Cocos nucifera Nutrition 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 235000020971 citrus fruits Nutrition 0.000 description 7
- 229940093499 ethyl acetate Drugs 0.000 description 7
- 235000019439 ethyl acetate Nutrition 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 244000037364 Cinnamomum aromaticum Species 0.000 description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 5
- 235000008708 Morus alba Nutrition 0.000 description 5
- 240000000249 Morus alba Species 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000002032 methanolic fraction Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000638 solvent extraction Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000006142 Luria-Bertani Agar Substances 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002036 chloroform fraction Substances 0.000 description 3
- -1 flavophopholipidol Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007952 growth promoter Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 235000014375 Curcuma Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001579180 Matthiola longipetala Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002034 butanolic fraction Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 244000038559 crop plants Species 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- NGSZDVVHIGAMOJ-YHYXMXQVSA-N (3z)-3-propylidene-2-benzofuran-1-one Chemical compound C1=CC=C2C(=C/CC)/OC(=O)C2=C1 NGSZDVVHIGAMOJ-YHYXMXQVSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 239000004190 Avilamycin Substances 0.000 description 1
- 229930192734 Avilamycin Natural products 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 241000737241 Cocos Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 229930191564 Monensin Natural products 0.000 description 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
- 241000157491 Morinda Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000722363 Piper Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 description 1
- 239000004189 Salinomycin Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 240000000278 Syzygium polyanthum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 240000003307 Zinnia violacea Species 0.000 description 1
- XIRGHRXBGGPPKY-OTPQUNEMSA-N [(2r,3s,4r,6s)-6-[(2'r,3's,3ar,4r,4'r,6s,7ar)-6-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4s,5s,6s)-6-[(2r,3as,3'ar,6'r,7r,7's,7ar,7'ar)-7'-acetyl-7'-hydroxy-6'-methyl-7-(2-methylpropanoyloxy)spiro[4,6,7,7a-tetrahydro-3ah-[1,3]dioxolo[4,5-c]pyran-2,4'-6,7a-dihydro-3ah- Chemical compound O([C@H]1[C@H](O)C[C@@H](O[C@@H]1C)O[C@H]1[C@H](O)CC2(O[C@]3(C)C[C@@H](O[C@H](C)[C@H]3O2)O[C@H]2[C@@H](OC)[C@@H](C)O[C@H]([C@@H]2O)O[C@H]2[C@H](O)[C@H](OC)[C@H](OC3[C@@H]([C@@H]4O[C@]5(O[C@H]4CO3)[C@@H]3OCO[C@H]3[C@@](O)([C@@H](C)O5)C(C)=O)OC(=O)C(C)C)O[C@@H]2COC)O[C@@H]1C)C(=O)C1=C(C)C(Cl)=C(O)C(Cl)=C1OC XIRGHRXBGGPPKY-OTPQUNEMSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960005185 avilamycin Drugs 0.000 description 1
- 235000019379 avilamycin Nutrition 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 231100000704 bioconcentration Toxicity 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000002815 broth microdilution Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000029182 enterotoxemia Diseases 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000012432 gingerbread Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000002044 hexane fraction Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229960005358 monensin Drugs 0.000 description 1
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960001548 salinomycin Drugs 0.000 description 1
- 235000019378 salinomycin Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Abstract
본 발명은 식물 또는 그 추출물을 유효성분으로 포함하는 병원성 미생물에 대한 항생용 조성물, 그 제조방법 및 상기 조성물의 사료에 응용에 관한 것이다.The present invention relates to an antibiotic composition against a pathogenic microorganism comprising the plant or its extract as an active ingredient, a method for preparing the same, and an application to the feed of the composition.
Description
본 발명은 식물의 추출물을 유효성분으로 포함하는 병원성 미생물에 대한 항생용 조성물에 관한 것으로 더욱 상세하게는 사이트러스 아우란티롤리아 스윙글(Citrus aurantifolia swingle;Lime), 사이트러스 아우란티롤리아 잎(Citrus aurantifolia swingle leaf;Lime leaf), 쿠르쿠마 도메스티가 바렌톤(Curcuma domestica Valeton;Turmeric), 세스바니아 그랜디프로라 (Sesbania grandiflora L). 및 파이퍼 사르멘토섬 로스브(Piper sarmentosum Roxb)로 구성된 군으로부터 선택된 하나 이상의 식물 및/또는 그 추출물을 유효성분으로 포함하는 병원성 미생물에 대한 항생용 조성물에 관한 것이다.The present invention relates to an antibiotic composition for pathogenic microorganisms comprising an extract of a plant as an active ingredient, and more specifically, Citrus aurantifolia swingle (Lime), Citrus aurantiolilia leaf (Citrus) aurantifolia swingle leaf; Lime leaf, Curcuma domestica Valeton; Turmeric, Sesbania grandiflora L. And it relates to an antibiotic composition for pathogenic microorganisms comprising one or more plants and / or extracts thereof selected from the group consisting of Piper sarmentosum Roxb as an active ingredient.
일반적으로 항생제는 인간뿐 아니라 축산업에 있어서 매우 중요한 역할을 한다. 과거 축산의 발전에 따라서 단위 면적당 사육두수가 증가되고 생산성을 향상시키기 위하여 질병의 예방 및 치료는 성공적인 축산의 중요한 요인으로 작용하였다. 이에 다양한 항생제와 성장촉진제들이 개발되었고, 현장에서 사용되어져 왔다. 이러한 항생제 사용량의 증가는 축산물에 대한 오염을 초래하였고, 더 나아가 생물농축현상을 통하여 축산물을 소비하는 인간의 생명을 위협하는 상황까지도 초래하였다.In general, antibiotics play a very important role in the livestock industry as well as in humans. In the past, with the development of livestock raising, the number of heads per unit area has increased and the prevention and treatment of disease has been an important factor for successful livestock raising. Various antibiotics and growth promoters have been developed and used in the field. The increased use of antibiotics has resulted in contamination of livestock products, and furthermore, bioconcentrations have led to life-threatening conditions for human consumption of livestock products.
또 항생제의 사용은 축산업의 발전에 있어 중요한 역할을 하나 내성균의 발생 등 다양한 부작용을 초래하였고, 또한 최근 친환경 농산물의 소비량 증가 및 요구도 증가로 인하여 항생제의 사용에 대한 부정적인 인식이 증가하였다. 실제로 EU(European Union)에서는 avilamycin, flavophopholipidol, salinomycin, monensin 4 종류의 항생제만을 허용하는 등 항생제에 대한 사용 규제를 강화하고 있는 실정이다. 또한 현재와 같이 급변하는 자유무역 체계에서 축산업의 생존을 위해서는 항생제의 사용을 원천적으로 배제하고 환경친화적으로 가축을 사육하는 것이 축산업 발전 및 국가 농업 발전에 있어 매우 중요한 과제이다. In addition, the use of antibiotics plays an important role in the development of the livestock industry, but it has caused various side effects such as the generation of resistant bacteria, and the recent increase in the consumption and demand of eco-friendly agricultural products has increased the negative recognition of the use of antibiotics. In fact, the European Union (EU) is tightening restrictions on the use of antibiotics such as allowing only four antibiotics, avilamycin, flavophopholipidol, salinomycin, and monensin. In addition, for the survival of livestock industry in today's fast-changing free trade system, it is important to exclude livestock and to raise livestock in an environmentally friendly manner.
친환경 축산의 구축을 위하여 항생제의 기능을 대체할 수 있는 환경친화적인 물질의 개발이 중요한 과제이다. 친환경 항생제 대체제는 다양한 분야에서 접근되어져 왔으며, 크게 병원성 미생물에 대하여 직접적인 길항작용을 나타내는 유용 미생물들을 중심으로한 생균제 (Probiotics)분야와 식물 및 기타 천연물질로부터 항균활성을 나타내는 물질을 개발하여 상용화하는 추출물 분야로 나뉠 수 있다 (김수기. 2005. 사료첨가용 식물추출물의 이용과 기능, 월간 피드저널).The development of environmentally friendly materials that can replace the function of antibiotics is an important task for the construction of environment-friendly livestock. Eco-friendly antibiotic substitutes have been approached in various fields, and extracts are developed and commercialized by probiotics, which are useful microorganisms that show direct antagonistic action against pathogenic microorganisms, and substances that exhibit antimicrobial activity from plants and other natural substances. It can be divided into fields (Kim Soo Ki. 2005. Use and function of plant extract for feed addition, monthly feed journal).
향료식물(herbs)과 같은 유용한 식물자원들은 직접적인 항균활성 기능 뿐만 아니라 수많은 생리활성물질 (bio-active chemical compounds)과 비타민, 칼슘, 철분 등의 다양한 영양소를 가지고 있어 질병예방 및 치료에 적용되어져 왔다. Useful plant resources, such as herbs, have been applied to disease prevention and treatment because of their direct antibacterial activity, as well as numerous bio-active chemical compounds and various nutrients such as vitamins, calcium and iron.
다양한 식물자원중 향료 식물은 일반적으로 향기가 있는 다년생 식물로서 식용, 향료, 의약 등으로 사용되어져 왔다. 특히 마늘, 겨자무(horseradish), 겨자, oregano 등은 일반 식품으로 널리 사용하여 왔고, 인삼, 향 아카시아, 쑥, 국화, 꽃창포, 구절초, 장미, 백일초, 천일홍, 계피나무, 향나무, 유자, 탱자 등의 향료식물들은 생리활성 기능이 우수하여 널리 이용되어져오고 있다.Perfume plants among various plant resources are generally scented perennial plants have been used as food, fragrance, medicine. In particular, garlic, horseradish, mustard, oregano have been widely used as general foods, ginseng, incense acacia, wormwood, chrysanthemum, irises, gujeolcho, rose, zinnia, cheonilhong, cinnamon, juniper, citron, tanza Perfume plants have been widely used because of their excellent biological activity.
식물자원에는 생리활성 기능 외에 다양한 병원성 미생물에 대한 항균활성을 나타내는 물질을 함유하고 있고, 식물자원에 존재하는 항균성 물질을 항균소재로 이용하고자 하는 연구는 식품, 의약 및 생물공학산업 등에서 오래전부터 활발하게 연구되어져 오고 있다. (Shin. D.H, Kim. M.S, Han. J.S. 1997. Korean J. Food SCI. TECHNOL . Vol. 29, pp. 808~816; Yang. M.S, Ha. Y.L, Nam. S.H, Choi. S.U, Jang. D.S. 1995. Korean SOC . ApplI . Bio . Chem . Vol. 38, pp. 584~589). In addition to its physiological activity, plant resources contain substances that exhibit antimicrobial activity against various pathogenic microorganisms. Research into the use of antimicrobial substances in plant resources as an antimicrobial material has been active in food, medicine, and biotechnology industries for a long time. It has been studied. (Shin. DH, Kim. MS, Han. JS 1997. Korean J. Food SCI. TECHNOL . Vol. 29, pp. 808-816; Yang. MS, Ha. YL, Nam. SH, Choi. SU, Jang. DS 1995. Korean SOC . ApplI . Bio . Chem . Vol. 38, pp. 584-589).
항균활성 및 약리활성을 지닌 식물자원은 지구상에 약 250,000~500,000종이 존재하고 있으나 이중 단지 1%만이 항균활성 및 생리활성에 대한 가능성을 평가받은 실정이다 (Cowan. M.M. 1999. Clin. Microbiol. Rev. 14, 564.584.). 이에 다양한 식물자원의 탐색 및 항균활성 스크리닝 연구는 매우 가치가 있는 분야로서 항생제 대체물질 개발에 있어 중요한 역할을 할 수 있다.There are about 250,000 to 500,000 species of plant resources with antimicrobial and pharmacological activity, but only 1% of them have been evaluated for their antimicrobial and physiological activity (Cowan. MM 1999. Clin. Microbiol. Rev. 14, 564.584.). Therefore, exploration of various plant resources and screening of antimicrobial activity are very valuable fields and can play an important role in the development of antibiotic substitutes.
본 발명은 상기의 문제점을 해결하고, 상기의 필요성에 의하여 안출된 것으로서 본 발명의 목적은 항생제의 사용을 대체할 수 있는 식물 추출물을 제공하는 것이다. The present invention solves the above problems, and the object of the present invention as devised by the above necessity is to provide a plant extract that can replace the use of antibiotics.
본 발명은 또 다른 목적은 상기 식물 또는 그 식물 추출물의 사료의 용도를 제공하는 것이다. Another object of the present invention is to provide a use of the feed of the plant or its plant extracts.
상기의 목적을 달성하기 위하여 본 발명은 사이트러스 아우란티롤리아 스윙글(Citrus aurantifolia swingle;Lime), 사이트러스 아우란티롤리아 잎(Citrus aurantifolia swingle leaf;Lime leaf), 쿠르쿠마 도메스티가 바렌톤(Curcuma domestica Valeton;Turmeric), 세스바니아 그랜디프로라 (Sesbania grandiflora L), 및 파이퍼 사르멘토섬 로스브(Piper sarmentosum Roxb)로 구성된 군으로부터 선택된 하나 이상의 식물 또는 그 식물의 추출물을 유효성분으로 포함하는 병원성 미생물에 대한 항생용 조성물을 제공한다.In order to achieve the above object, the present invention provides a citrus aurantifolia swingle (Lime), a citrus aurantifolia swingle leaf (Lime leaf), Curcuma domestiga barenton (Curcuma domestica Valeton; Turmeric), Sesbania grandiflora L, and Piper sarmentosum Roxb selected from the group consisting of or an extract of the plant as an active ingredient Provided is an antibiotic composition for pathogenic microorganisms.
또한 본 발명은 사이트러스 아우란티롤리아 스윙글(Citrus aurantifolia swingle;Lime), 사이트러스 아우란티롤리아 잎(Citrus aurantifolia swingle leaf;Lime leaf), 쿠르쿠마 도메스티가 바렌톤(Curcuma domestica Valeton;Turmeric), 세스바니아 그랜디프로라 (Sesbania grandiflora L), 및 파이퍼 사르멘토섬 로스브(Piper sarmentosum Roxb) 및 으로 구성된 군으로부터 선택된 하나 이상의 식물을 물 또는 유기용매로 추출하고 정제하는 단계를 포함하는 병원성 미생물에 대한 항생용 조성물 제조방법을 제공한다.In another aspect, the present invention is Citrus aurantifolia swingle (Lime), Citrus aurantifolia swingle leaf (Lime leaf), Curcuma domestica Valeton (Turmeric) ), Sesbania grandiflora L, and Piper sarmentosum Roxb and one or more plants selected from the group consisting of extracting and purifying with water or an organic solvent. It provides a method for preparing an antibiotic composition.
또한 본 발명은 사이트러스 아우란티롤리아 스윙글(Citrus aurantifolia swingle;Lime), 사이트러스 아우란티롤리아 잎(Citrus aurantifolia swingle leaf;Lime leaf), 쿠르쿠마 도메스티가 바렌톤(Curcuma domestica Valeton;Turmeric), 세스바니아 그랜디프로라 (Sesbania grandiflora L), 및 파이퍼 사르멘토섬 로스브(Piper sarmentosum Roxb)로 구성된 군으로부터 선택된 하나 이상의 식물 또는 그 식물의 추출물을 포함하는 사료용 조성물을 제공한다.In another aspect, the present invention is Citrus aurantifolia swingle (Lime), Citrus aurantifolia swingle leaf (Lime leaf), Curcuma domestica Valeton (Turmeric) ), Sesbania grandiflora L, and Piper sarmentosum Roxb. Provided are feed compositions comprising one or more plants or extracts thereof.
이하, 본 발명을 설명한다.Hereinafter, the present invention will be described.
본 발명은 적합한 담체 또는 사료 보충물의 형태에 혼합된 상기 본 발명의 식물 또는 그 추출물물을 활성성분으로 구성된 수의 또는 축산 용도의 조성물에 관한 것이다.The present invention relates to a composition for veterinary or animal husbandry use comprising the active ingredient of the plant of the present invention or an extract thereof mixed in the form of a suitable carrier or feed supplement.
언급된 조성물은 항생제의 결점과 부작용의 유발 없이, 동물 특히 가축 예를 들어 돼지(swine), 소(bovine), 양(ovine), 닭, 또는 말(equine) 등에 유용하게 사용될 수 있다.The mentioned compositions can be usefully used in animals, especially livestock such as swine, bovine, ovine, chicken, or equine, without inducing the drawbacks and side effects of antibiotics.
복용량은 동물의 종(species), 크기(size), 무게(weight), 나이(age)와 같은 다수의 요인들에 좌우될 것이다. 원칙적으로, 전형적인 복용량은 동물/일 당 0.1 - 10 g의 추출물 또는 식물 범위일 것이다.Dosage will depend on a number of factors such as the species, size, weight and age of the animal. In principle, typical dosages will be in the range of 0.1-10 g of extract or plant per animal / day.
본 발명에 따른 사용 가능한 추출물은 다음과 같이 구성된 공정에 의해 제조될 수 있다 :a) 용매로 상기 식물을 추출하고, 그리고 선택적으로 b) 물 불용성으로부터 정제한다.Usable extracts according to the invention can be prepared by a process consisting of: a) extracting the plant with a solvent, and optionally b) purifying from water insolubility.
본 발명의 식물 또는 식물의 일부의 추출물을 생성하는 경우, 물, 유기 용매 또는 이의 혼합물은 전형적인 방법에 따라 제조될 수 있지만, 무수 증류물 또한 적용될 수 있다. 적합한 유기 용매의 예는 메탄올, 에탄올, 프로판올, 부탄올, 메틸 아세테이트, 에틸 아세테이트, 메틸 에틸 에테르, 다이에틸 에테르, 메틸렌 클로라이드, 클로로폼, 사염화탄소, 벤젠, 톨루엔, 헥산, 바셀린 또는 아세톤이다. 본 발명의 추출은 또한 상기의 용매 추출 및/또는 기계적인 추출의 사용을 수반한다. 추출 온도는 5 ℃에서 선택된 용매의 끊는 온도까지의 범위가 가능하다.When producing extracts of plants or parts of plants of the invention, water, organic solvents or mixtures thereof can be prepared according to typical methods, but anhydrous distillates can also be applied. Examples of suitable organic solvents are methanol, ethanol, propanol, butanol, methyl acetate, ethyl acetate, methyl ethyl ether, diethyl ether, methylene chloride, chloroform, carbon tetrachloride, benzene, toluene, hexane, petrolatum or acetone. Extraction of the invention also involves the use of such solvent extraction and / or mechanical extraction. The extraction temperature can range from 5 ° C. up to the breaking temperature of the selected solvent.
천연 추출물은 물에 녹지 않는 것을 제거하여 정제시킬 수 있다(단계(b)).Natural extracts can be purified by removing insoluble in water (step (b)).
단계(a)에서 천연 추출물은 용액에서 알콜(또는 위에 인용된 것들중 사용된 어떤 다른 용매)을 완전히 제거하는, 60 ℃의 감압 하에서 농축시키고, 다음으로 추출물은 5 % w/w - 55 % w/w, 바람직하게는 25 % w/w 건조 잔사로 농축시키고, 온도를 1 ℃ - 30 ℃, 바람직하게는 4 ℃로, 1 시간 - 32 시간, 바람직하게는 16 시간 동안 교반 없이 유지시켰다.In step (a) the natural extract is concentrated under reduced pressure at 60 ° C. to completely remove alcohol (or any other solvent used among those quoted above) from the solution, and the extract is then extracted from 5% w / w-55% w. / w, preferably to 25% w / w dry residue, and the temperature was maintained at 1 ° C-30 ° C, preferably 4 ° C, without stirring for 1 hour-32 hours, preferably 16 hours.
정제된 추출물로 구성하는, 얻어진 맑은 용액을 원심분리(centrifugation)시켜 불용물로부터 분리시켰다.The resulting clear solution, consisting of purified extracts, was separated from insolubles by centrifugation.
동물에 투여되는 성분의 총 양은 성분이 필수 화합물인지, 식물 물질의 추출물인지 식물 물질인지에 따른다. 성분이 단지 식물 물질로 구성되는 경우, 투여되는 양은 일반적으로 하루에 체중 1kg당 0.02 내지 10g이다.The total amount of ingredient administered to the animal depends on whether the ingredient is an essential compound, an extract of the plant material or a plant material. If the ingredients consist only of plant material, the amount administered is generally from 0.02 to 10 g per kg of body weight per day.
본 발명의 조성물은 본 발명의 성분이 아닌 다른 성분을 함유할 수 있다. 적합하게는 첨가제는 성장 촉진제, 향료, 흡수 지지체 및/또는 다른 사료 성분 뿐만 아니라, 0.1 내지 100중량%, 바람직하게는 0.2 내지 90중량%의 성분을 함유한다. 바람직하게는, 성장 촉진제, 향료, 흡수 지지체 및/또는 다른 사료 성분의 총 양은 첨가제의 10 내지 75중량%이다. 임의의 성분이 식물 물질인 경우, 이들은 첨가제 중의 임의의 다른 성분과 혼합되기 전에 적합하게 건조되고, 미립자 또는 분말로 분쇄된다.The composition of the present invention may contain components other than the components of the present invention. Suitably the additive contains 0.1 to 100% by weight, preferably 0.2 to 90% by weight, as well as growth promoters, flavorings, absorbent supports and / or other feed ingredients. Preferably, the total amount of growth promoter, fragrance, absorbent support and / or other feed ingredient is 10 to 75% by weight of the additive. If any of the ingredients is a plant material, they are suitably dried and ground into fines or powders before mixing with any other ingredients in the additive.
적합한 성장 촉진 첨가제 및 향료의 예는 크레졸, 아네톨, 데카락톤, 운데카락톤 및/또는 도데카락톤, 이오논(ionone), 아이론(irone), 진저롤, 피페리딘, 프로필리덴 프탈라이드, 부틸리덴 프탈라이드, 캡사이신 및/또는 타닌산이다. 지지체는 예를 들면 40 내지 50중량%의 목재 섬유, 8 내지 10중량%의 스테아린, 4 내지 5중량%의 강황 분말, 4 내지 5중량%의 로즈마리 분말, 22 내지 28중량%의 석회석, 1 내지 3중량%의 고무, 예를 들면 아라비아 고무, 5 내지 50중량%의 당 및/또는 전분 및 5 내지 15중량%의 물을 함유할 수 있다. 다른 사료 성분은 적합하게는 비타민, 효소, 무기 염, 분쇄된 곡물, 단백질함유 성분, 탄수화물-함유 성분, 거친 밀가루 및/또는 밀기울로 구성된 군에서 선택된다. 첨가제는 적합하게는 사료가 0.4ppm 내지 80중량%의 성분을 함유하게 하는 양으로 본 발명에 따른 사료 조성물에 첨가된다.Examples of suitable growth promoting additives and fragrances are cresol, anetol, decaractone, undecaractone and / or dodecaractone, ionone, ironone, gingerbread, piperidine, propylidene phthalide, boolean Tilidene phthalide, capsaicin and / or tannic acid. The support is for example 40 to 50% by weight wood fibers, 8 to 10% by weight stearin, 4 to 5% turmeric powder, 4 to 5% rosemary powder, 22 to 28% limestone, 1 to It may contain 3% by weight rubber, for example gum arabic, 5-50% by weight sugar and / or starch and 5-15% by weight water. Other feed ingredients are suitably selected from the group consisting of vitamins, enzymes, inorganic salts, ground grains, protein containing ingredients, carbohydrate-containing ingredients, coarse flour and / or bran. The additive is suitably added to the feed composition according to the present invention in an amount such that the feed contains 0.4 ppm to 80% by weight of the component.
본 발명에 따른 사료 조성물은 일반적으로, 사료의 건조 중량을 기준으로 계산하였을 때 다음과 같은 성분을 함유한다:Feed compositions according to the invention generally contain the following ingredients as calculated on the basis of the dry weight of the feed:
a) 0 내지 80 무수 중량%의 곡류,b) 0 내지 30 무수 중량%의 지방, c) 0 내지 85 무수 중량%의, 곡류 이외의 유형의 단백질-함유 영양 물질, 및 d) 10ppm 내지 40 무수 중량%의 본 발명의 성분. a) 내지 d)의 총 양은 바람직하게는 최소한 50무수중량%이다.a) from 0 to 80% by weight of cereals, b) from 0 to 30% by weight of fat, c) from 0 to 85% by weight of anhydrous protein-containing nutrients other than cereals, and d) from 10 ppm to 40% of anhydrous. % By weight of the component of the invention. The total amount of a) to d) is preferably at least 50% by weight anhydrous.
사료 조성물을 제조하는 경우, 첨가제는 곡류, 예를 들면 연마되거나 분쇄된 밀, 귀리, 보리, 옥수수 및 쌀; 평지씨, 대두콩 및 해바라기 씨에 근거한 식물성 단백질 공급원; 동물성 단백질 공급원; 당밀; 및 우유 제품, 예를 들면 다양한 우유 분말 및 유장 분말로 구성된 건조 성분과 혼합될 수 있다. 모든 건조 성분과 혼합된 후, 액체 성분 및 가열후 액체가 된 성분을 첨가할 수 있다. 액체 성분은, 선택적으로 가열에 의해 액화된 지질, 예를 들면 지방, 예를 들면 식물성 지방, 및/또는 카복실산,예를 들면 지방산으로 구성될 수 있다. 완전히 혼합한 후, 성분의 연마도에 따라 가루 또는 입자상 농도가 수득된다. 저장하는 동안 분리되는 것을 방지하기 위해서, 물을 바람직하게는 동물 사료에 첨가해야만 하고, 이 사료는 후속적으로 종래의 펠렛화, 증량 또는 압출 공정으로 처리된다. 임의의 추가의 물을 건조에 의해 제거할 수 있다. 원하는 경우, 생성된 입자상 동물 사료를 더 작은 입자 크기로 분쇄할 수 있다. 개시된 사료 조성물은 일반적으로 건조된 녹색 꼴 및/또는 목초와 조합되어 투여된다.When preparing the feed composition, the additives may be cereals such as milled or ground wheat, oats, barley, corn and rice; Vegetable protein sources based on rapeseed, soybean and sunflower seeds; Animal protein sources; molasses; And dry ingredients consisting of milk products such as various milk powders and whey powders. After mixing with all the dry ingredients, the liquid ingredients and the ingredients which become liquid after heating can be added. The liquid component may consist of lipids, such as fats, for example vegetable fats, and / or carboxylic acids, for example fatty acids, optionally liquefied by heating. After complete mixing, a powder or particulate concentration is obtained depending on the degree of polishing of the components. In order to prevent segregation during storage, water should preferably be added to the animal feed, which is subsequently processed by conventional pelletization, extension or extrusion processes. Any additional water can be removed by drying. If desired, the resulting particulate animal feed can be ground to smaller particle sizes. The disclosed feed compositions are generally administered in combination with dried green grass and / or grasses.
식수 보충물은 1 무수 중량% 이상, 적합하게는 1 내지 99 무수 중량%, 바람직하게는 10 내지 50 무수 중량%의 성분을 함유할 수 있다. 하나 이상의 성분에 추가하여, 보충물은 더 많은 수의 다른 성분을 1 내지 99 무수 중량%로 함유할 수 있다.The drinking water supplement may contain at least 1% by weight anhydrous, suitably 1 to 99% anhydrous, preferably 10 to 50% anhydrous. In addition to one or more ingredients, the supplement may contain from 1 to 99 anhydrous weight percent of a greater number of other ingredients.
다른 성분의 적합한 예는 광물성 염, 비타민, 건강 및 성장 개선 첨가제, 향료, 수용성 또는 수-분산성 담체, 예를 들면 당,분말 우유, 우유 부산물 및 셀룰로즈 유도체, 분산제 및 안정화제, 예를 들면 수용성 또는 수-분산성 중합체 및 이의 혼합물이다. 식수를 제조하는 경우, 보충물은 일반적으로 성분의 농도가 1ppm 내지 10중량%가 되는 양으로 물에 첨가된다.Suitable examples of other ingredients are mineral salts, vitamins, health and growth improving additives, perfumes, water soluble or water dispersible carriers such as sugars, powdered milk, milk by-products and cellulose derivatives, dispersants and stabilizers such as water soluble Or water-dispersible polymers and mixtures thereof. When preparing drinking water, the replenishment is generally added to the water in an amount such that the concentration of the component is from 1 ppm to 10% by weight.
본 발명의 범위 이내에서, 사료 조성물의 현탁액을 제조하는 것 또한 가능하다. 사료가 즉각적인 소비를 위해 제조되는 경우 이는 특히 편리하다.Within the scope of the present invention, it is also possible to prepare suspensions of the feed composition. This is particularly convenient when the feed is prepared for immediate consumption.
본 발명에서는 가축에게 사용되는 항생제중 병원성 세균에 의한 질병을 예방 및 치료를 목적으로하는 항생제를 대체하기 위하여 잠재력이 있는 유용 식물자원을 탐색하고 항균활성 스펙트럼을 조사하기 위하여 수행되었다. 특히 약리기능이 우수한 것으로 잘 알려진 야생 식물 중, 비교적 서식지가 넓고 대량으로 자생하고 있는 식물들을 대상으로 가축의 소화기성 질병 및 호흡기 질병에 관여하는 주요 병원성 미생물에 대한 항균활성 스펙트럼을 조사하였다. 또한 항균활성 물질의 규명을 위하여 각 식물체에 대한 다양한 용매 추출 분획을 확보하고, 항균활성 스펙트럼을 조사하였다. In the present invention, it was carried out to search for useful plant resources with potential to replace antibiotics for the purpose of preventing and treating diseases caused by pathogenic bacteria among antibiotics used in livestock and to investigate the antimicrobial activity spectrum. In particular, we examined the antimicrobial activity spectrum of major pathogenic microorganisms involved in livestock digestive and respiratory diseases among wild plants known for their excellent pharmacological function. In addition, various solvent extraction fractions were obtained for each plant for identification of antimicrobial active substances, and antimicrobial activity spectra were investigated.
보다 세밀한 식물 추출물의 항균활성을 평가하기 위하여 열수추출 방법과 methanol, n-hexane, chloroform, ethtyl acetate 그리고 butanol 등 다양한 용매를 이용한 분획을 확보하였고, Clostridium perfringens Type E, Enterotoxigenic E. coli, Burkholderia sp, Pantoea agglomerans, Haemopillus parsuis, 그리고 Haemopillus somnus 등 가축의 질병을 유발하는 6종의 주요 병원성 세균에 대한 항균활성을 paper disc methods를 이용하여 평가하였다. In order to evaluate the antimicrobial activity of more detailed plant extracts, hot water extraction method and fractions using various solvents such as methanol, n-hexane, chloroform, ethtyl acetate and butanol were obtained, and Clostridium perfringens Type E, Enterotoxigenic E. coli, Burkholderia sp, The antimicrobial activity of six major pathogenic bacteria, including Pantoea agglomerans, Haemopillus parsuis, and Haemopillus somnus, caused animal disease was evaluated using paper disc methods.
Piper sarmentosum Roxb(Wild Betal)의 경우 methanol 추출 분획에서 미약한 항균활성을 나타내었으며, Citrus aurantifolia swingle leaf(Lime leaf)의 경우 methanol, hexane 그리고 chloroform 추출분획에서 미약한 항균활성을 나타내었으며, Burkholderia sp에 특이적인 항균활성을 나타내었다. Curcuma domestica Valeton(Turmeric)의 경우 모든 용매 추출 분획에서 항균활성을 나타내지 않았으나 열수 추출 분획에서 Clostridium perfringens에 대하여 특이적인 항균활성을 나타내었으며, 항균력 또한 매우 우수하였다. Sesbania grandiflora L.경우 대부분의 추출분획에서 항균활성이 나타나지 않았으나, butanol fraction에서 Burkholderia sp.에 대한 항균활성이 나타났다. Citrus aurantifolia swingle(Lime)의 경우 열수추출분획과 methanol 추출 분획에서 매우 우수한 항균력을 나타내었으며, 다른 식물 추출물에 비하여 매우 우수한 항균력을 나타내었다.Piper sarmentosum Roxb (Wild Betal) showed weak antimicrobial activity in methanol extract fraction, and Citrus aurantifolia swingle leaf (Lime leaf) showed weak antimicrobial activity in methanol, hexane and chloroform extract fractions. Specific antimicrobial activity was shown. Curcuma domestica Valeton (Turmeric) showed no antimicrobial activity in all solvent extract fractions, but showed specific antimicrobial activity against Clostridium perfringens in hydrothermal extract fractions. Sesbania grandiflora L. did not show antimicrobial activity in most of the extract fractions, but showed antimicrobial activity against Burkholderia sp. In the butanol fraction. Citrus aurantifolia swingle (Lime) showed very good antimicrobial activity in the hot water extract and methanol extract fractions, and showed very good antimicrobial activity compared to other plant extracts.
항균활성이 확인된 물질들을 대상으로 MIC (minimum inhibition concentration)를 조사한 결과 Sesbania grandiflora L(Agati sesbania,Bai Khae)의 buthanol 추출물에서 호흡기 병원균인 Burkholderia sp에 대한 MIC 농도가 135 ㎍/㎖로 가장 강한 항균 활성을 나타내었다. Sesbania was tested on the MIC (minimum inhibition concentration) of the substances with antimicrobial activity. of grandiflora L (Agati sesbania, Bai Khae) Burkholderia , a respiratory pathogen, from buthanol extract for sp MIC concentration of 135 μg / ml showed the strongest antimicrobial activity.
항산화활성 평가에서는 대부분의 식물들이 비교적 높은 항산화 활성을 나타내었고, 특히 Citrus aurantifolia swingle(Lime), Citrus aurantifolia swingle leaf(Lime leaf), Morinda citrifolia L. leaf(Beach mulberry leaf), Piper sarmentosum Roxb(Wild Betal), Curcuma domestica Valeton(Turmeric), Cassia siamea britt(Siamea Cassia) 등의 methnol 추출물이 높은 활성을 나타내었다.In the evaluation of antioxidant activity, most plants showed relatively high antioxidant activity, especially Citrus aurantifolia swingle (Lime), Citrus aurantifolia swingle leaf (Lime leaf), Morinda citrifolia L. leaf (Beach mulberry leaf), Piper sarmentosum Roxb (Wild Betal), Curcuma domestica Valeton (Turmeric), Cassia siamea britt (Siamea Cassia) Methnol extract showed high activity.
일련의 본 발명의 결과를 종합한 결과 Sesbania grandiflora L(Agati sesbania,Bai Khae)의 buthanol 추출물에서 호흡기 병원균인 Burkholderia sp .에 대한 가장 강한 항균 활성을 나타내었고, 항산화활성 평가 대부분의 식물에서 비교적 높은 항산화 활성을 나타내었고, 특히 Citrus aurantifolia swingle(Lime), Citrus aurantifolia swingle leaf(Lime leaf), Piper sarmentosum Roxb(Wild Betal), Curcuma domestica Valeton(Turmeric) 등에서 유래한 추출물이 높은 활성을 나타내어 항생제 대체제로서 개발 가능성이 높다. The result of the synthesis of a series of the present invention Sesbania of grandiflora L (Agati sesbania, Bai Khae) Burkholderia , a respiratory pathogen, from buthanol extract sp . For It showed the strongest antimicrobial activity, and antioxidative activity evaluation showed relatively high antioxidant activity in most plants, especially Citrus aurantifolia swingle (Lime), Citrus aurantifolia swingle leaf (Lime leaf), Piper sarmentosum Roxb (Wild Betal), Curcuma domestica Valeton (Turmeric) The extract derived from the back shows high activity and is highly likely to be developed as an antibiotic substitute.
도 1은 본 발명에 사용된 열대식물의 사진이다. 사진에서 A.Citrus aurantifolia swingle; B.Citrus aurantifolia swingle leaf; C.Cassia siamea britt; D.Cocos nucifera L.; E.Morinda citrifolia L. leaf.; F.Sesbania grandiflora L.; G,Piper sarmentosum Roxb; H.Curcuma domestica Valeton를 나타낸다.
도 2는 열대 식물의 여러 추출단계를 나타낸다.1 is a photograph of a tropical plant used in the present invention. A.Citrus aurantifolia swingle in photo; B.Citrus aurantifolia swingle leaf; C. Cassia siamea britt; D. Cocos nucifera L .; E.Morinda citrifolia L. leaf .; F. Sesbania grandiflora L .; G, Piper sarmentosum Roxb; H. Curcuma domestica Valeton.
2 shows several extraction steps of tropical plants.
이하, 비한정적인 실시예를 통하여 본 발명을 더욱 상세하게 설명한다. 단 하기의 실시예는 본 발명을 설명하는 것이지 하기 실시예에 의하여 본 발명의 범위를 한정하려는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to non-limiting examples. However, the following examples are intended to illustrate the present invention and are not intended to limit the scope of the present invention by the following examples.
실시예Example 1:후보 식물 1: candidate plant
다양한 병원균에 대한 항균활성이 우수한 천연 식물자원을 탐색하기 위하여 본 실험에서는 현재 열대지방에서 자생하고 있는 열대 식물들을 대상으로 항균활성을 평가하였다.In order to search for natural plant resources with excellent antimicrobial activity against various pathogens, this study evaluated antimicrobial activity against tropical plants currently growing in the tropics.
열대지방에서 자생하고 있는 Citrus aurantifolia swingle(Lime), Citrus aurantifolia swingle leaf(Lime leaf,), Morinda citrifolia L. leaf(Beach mulberry leaf), Sesbania grandiflora L.(Agati sesbania,), Piper sarmentosum Roxb(Wild Betal), Curcuma domestica Valeton(Turmeric), Cassia siamea britt(Siamea Cassia) 그리고 Cocos nucifera L.(Coconut)을 식물자원으로 사용하였고, 본 발명에 사용한 각 식물은 도 1 또는 표 1에서 보는 것과 같다. Citrus grows in the tropics aurantifolia swingle (Lime), Citrus aurantifolia swingle leaf (Lime leaf,), Morinda citrifolia L. leaf (Beach mulberry leaf), Sesbania grandiflora L. (Agati sesbania,), Piper sarmentosum Roxb (Wild Betal), Curcuma domestica Valeton (Turmeric), Cassia siamea britt (Siamea Cassia) and Cocos nucifera L. (Coconut) was used as a plant resource, each plant used in the present invention is as shown in Figure 1 or Table 1.
각 식물체는 수집 후에 증류수를 이용하여 2~3회 세척하였고, 킴와이프 티슈를 이용하여 물기를 제거한 후 48시간 동안 음건하였고, 건조된 시료는 분쇄기를 이용하여 분쇄한 후 추출시료로 사용하였다. Each plant was washed 2-3 times with distilled water after collection, and dried for 48 hours after removing water with Kimwi tissue, and the dried sample was pulverized using a grinder and used as an extract sample.
상기 표 1은 본 발명에 사용된 열대식물의 이름이다.Table 1 is a name of tropical plants used in the present invention.
실시예Example 2: 항균활성 평가를 위한 추출물 및 2: extract for evaluation of antimicrobial activity and 분획물의Fraction 조제 pharmacy
각 식물체의 추출물 제조는 한 (2005)의 방법에 기초하여 단계별 추출 분획을 확보하였다. 상세한 추출 분획 회수 방법은 다음과 같다. 건조 후 분쇄된 각 식물체 3g을 메탄올 27 ml와 혼합한 후에 실온에서 약 6시간 동안 150rpm으로 교반 추출하였다. methanol 추출물은 여과지 (Whatman filter paper No 2)를 이용하여 잔사를 제거하고 여과액을 회수하였다. 여과액은 감압 농축하여 최종 methanol 분획으로 회수하였다. 회수된 methanol 분획은 일부 항균활성 평가에 사용하였고 나머지는 극성에 따라 n-hexane, chloroform, ethylacetate, butanol등 순차적으로 용매 분획하였다 (도 2).Extract preparation of each plant was obtained step by step extraction fraction based on the method of (2005). Detailed extraction fraction recovery method is as follows. After drying, 3 g of each ground plant was mixed with 27 ml of methanol, and extracted by stirring at 150 rpm for about 6 hours at room temperature. The methanol extract was removed using a filter paper (Whatman filter paper No 2) to recover the filtrate. The filtrate was concentrated under reduced pressure and recovered to the final methanol fraction. The recovered methanol fraction was used for the evaluation of some antimicrobial activity, and the rest were solvent fractions sequentially, such as n-hexane, chloroform, ethylacetate, butanol, depending on polarity (FIG. 2).
감압 농축된 methanol 분획과 3차 증류수, 그리고 n-hexane을 1:1의 비율로 혼합한 후, voltex mixer를 이용하여 교반하였다. 용매 혼합액은 상온에서 정치시켜 tube내 층분리를 유도하였고, pasteur pippet를 이용하여 n-hexane 층을 회수하였다. 회수된 n-hexane 층은 감압 농축하여 항균활성 평가에 사용하였고, 나머지 물층은 3차증류수와 chloroform을 1:1의 비율로 혼합한 후 교반하였다. 교반 후에 정치시켜 층분리를 유도하였고 pasteur pippet를 이용하여 chloroform 층을 회수하였다. 회수된 chloroform 분획은 감압 농축하여 항균활성을 평가하였고 나머지 물층은 3차 증류수와 ethylacetate (1:1)와 혼합한 후에 chloroform 분획 회수 방법과 동일하게 ethylacetate 층과 물층을 분리하였고, ethylacetate 분획은 감압 농축하여 항균활성 평가에 사용하였고, 나머지 물층은 3차 증류수와 butanol (1:1)과 혼합한 후, 위와 동일한 방법으로 최종 butanol 분획을 회수하였다. 일련의 방법은 도 2에서 보는 것과 같다. 감압농축을 통하여 회수한 각 분획물은 해당 용매로 다시 용해시켜 4℃에서 보관하며 항균활성 평가에 사용하였다.The methanol fractions concentrated under reduced pressure, tertiary distilled water, and n-hexane were mixed at a ratio of 1: 1, followed by stirring using a voltex mixer. The solvent mixture was allowed to stand at room temperature to induce tube separation, and the n-hexane layer was recovered using pasteur pippet. The recovered n-hexane layer was concentrated under reduced pressure and used for evaluation of antimicrobial activity. The remaining water layer was mixed with tertiary distilled water and chloroform in a ratio of 1: 1 and stirred. After stirring, the mixture was left to induce delamination and the chloroform layer was recovered using pasteur pippet. The recovered chloroform fraction was concentrated under reduced pressure to evaluate the antimicrobial activity. The remaining water layer was mixed with tertiary distilled water and ethylacetate (1: 1), and the ethylacetate layer and the water layer were separated in the same manner as the chloroform fraction recovery method. The ethylacetate fraction was concentrated under reduced pressure. Was used for the evaluation of antimicrobial activity, and the remaining water layer was mixed with tertiary distilled water and butanol (1: 1), and the final butanol fraction was recovered in the same manner as above. The series of methods is as shown in FIG. Each fraction recovered through vacuum concentration was dissolved again with the corresponding solvent and stored at 4 ° C and used for antimicrobial activity evaluation.
실시예Example 3: 가축 병원성 세균에 대한 식물 추출물의 항균활성 평가 3: Evaluation of antimicrobial activity of plant extracts against livestock pathogenic bacteria
다양한 용매로 분획된 추출물은 주요 가축병원성 세균에 대하여 항균활성을 평가하여, 우수한 식물 추출물을 선별하였다.Extracts fractionated with various solvents were evaluated for antimicrobial activity against major livestock pathogenic bacteria, and excellent plant extracts were selected.
실시예Example 4: 병원균의 준비 4: preparation of pathogens
본 발명에서 사용된 병원균은 가축의 소화기성 질병과 호흡기 질병 등을 유발하는 주요 병원성 세균으로 수의과학검역원에서 분양받아 사용하였고, 각 균주는 표 2에서 보는 것과 같다.The pathogen used in the present invention was used as a major pathogenic bacterium causing animal digestive diseases and respiratory diseases, and was used by veterinary quarantine officers, and each strain is shown in Table 2.
-70℃에 보관된 각 병원균은 멸균된 백금이를 이용하여 LB agar에 streak 한 후, 37℃에서 24시간 동안 배양하였다. LB agar 표면에 나타난 각 병원성 세균의 colony 중 하나를 백금이를 이용하여 취한 후, LB broth에 옮겨 37℃ 진탕배양기에서 200rpm으로 24시간 배양한 후 피검균으로 사용하였다.Each pathogen stored at -70 ° C was streaked in LB agar using sterile platinum and then incubated at 37 ° C for 24 hours. One of the colonies of each pathogenic bacterium that appeared on the surface of LB agar was taken using platinum teeth, and then transferred to LB broth and incubated at 200 rpm for 24 hours in a 37 ° C shake incubator.
Type E Clostridium perfringens
Type E
partialpartial
표 2는 본 발명에 사용된 병원성 세균에 대한 리스트이고, *National Veterinary Research Quarantine Service(수의과학검역원)을 나타낸다.Table 2 is a list of pathogenic bacteria used in the present invention and represents the * National Veterinary Research Quarantine Service.
실시예Example 5: 항균활성 평가를 위한 중층 배지의 제조 5: Preparation of Stratified Media for Evaluation of Antimicrobial Activity
각 식물 추출물 분획의 항균활성을 평가하기 위하여, 병원균의 준비는 중층 배지 방법을 사용하였다. 항균활성 시험에 사용된 중층 배지는 0.8% agar (Bacto agar, Difco) 용액을 15ml screw cap tube 에 10ml 씩 나누어 담고, 121℃에서 15분간 멸균하여 준비하였고, tube의 agar가 굳지 않게 하기 위하여 50℃ water bath에서 보관하였다. In order to evaluate the antimicrobial activity of each plant extract fraction, the preparation of the pathogen was used in the medium culture method. The medium layer used in the antimicrobial activity test was prepared by diluting 0.8% agar (Bacto agar, Difco) solution in 10 ml of 15 ml screw cap tubes, sterilizing for 15 minutes at 121 ℃, 50 ℃ in order to prevent the agar of the tube to harden Stored in water bath.
배양된 병원균은 최종 농도를 1×107 ~ 1×108 cfu/ml가 되게 희석한 후에 50℃ water bath 보관된 멸균 0.8% agar 용액 tube에 100㎕를 접종하였고, voltex mixer를 이용하여 교반한 후에 LB agar plate에 붓고 상온에서 식히면서 고형화시켰다.The cultured pathogen was diluted to a final concentration of 1 × 10 7 to 1 × 10 8 cfu / ml, and then inoculated with 100 μl in a sterile 0.8% agar solution tube stored in a water bath at 50 ° C., and stirred using a voltex mixer. It was then poured into LB agar plate and solidified while cooling at room temperature.
실시예Example 6: 식물 추출물 분획의 항균활성 평가 6: Evaluation of antimicrobial activity of plant extract fractions
일련의 과정을 통하여 확보된 식물 추출물 분획의 항균활성은 윤 등(2005)의 방법에 따라서 paper disc method를 통하여 평가하였다. 용매별로 추출된 분획을 멸균된 6mm filter paper disk (Whatman AA Discs)에 25㎕씩 흡수시키고 상온에서 각 용매가 휘발되도록 30분간 방치하였다. 각 용매가 휘발된 후에 병원성 세균이 도말된 중층배지 위에 올려놓은 후, 37℃ incubator에서 24~48시간 동안 배양하였다. 배양 후 paper disc 주변으로 형성된 생육저지 환을 관찰하여 항균활성의 유무와 정도를 평가하였다.
The antimicrobial activity of the plant extract fractions obtained through a series of procedures was evaluated by the paper disc method according to Yun et al. (2005). The fractions extracted for each solvent were absorbed by 25 µl in sterile 6 mm filter paper disk (Whatman AA Discs) and allowed to stand for 30 minutes to evaporate each solvent at room temperature. After each solvent was volatilized, the pathogenic bacteria were placed on the plated medium, and then incubated in a 37 ° C. incubator for 24 to 48 hours. After incubation, growth inhibition ring formed around the paper disc was observed to evaluate the presence and extent of antimicrobial activity.
실시예Example 7: 식물 추출물 분획의 최소저해농도( 7: Minimum inhibitory concentration of plant extract fraction ( MICMIC ) 평가 ) evaluation
각 균주의 최소저해농도(MIC)는 broth microdilution method에 의해 다음과 같이 측정하였다. 즉, 96웰 플레이트에 LB를 50㎕씩 분주하고 50㎕의 식물추출물을 two-fold dilution하여 농도를 조절한 후 균의 농도를 104~105 CFU/ml이 되도록 희석시켜 50㎕씩 첨가하였다. 그 후 37℃에서 16시간 이상 배양한 뒤, 600nm에서 microplate reader로 흡광도를 측정하였다. Turbidity가 나타나지 않은 well의 해당 시료 농도를 MIC(minimum inhibition concentration)값으로 결정하였다.
The minimum inhibitory concentration (MIC) of each strain was measured by the broth microdilution method as follows. That is, 50 μl of LB was dispensed into 96-well plates, 50 μl of plant extracts were adjusted by two-fold dilution, and the concentration of bacteria was diluted to 10 4 to 10 5 CFU / ml, and 50 μl was added thereto. . After incubation for 16 hours or more at 37 ℃, the absorbance was measured with a microplate reader at 600nm. The concentration of the sample in wells without turbidity was determined as the MIC (minimum inhibition concentration).
실시예Example 8: 식물 추출물 분획의 항산화활성 평가 8: Evaluation of Antioxidant Activity of Plant Extract Fractions
항산화 활성은 DPPH photometric assay를 사용하였다. Ethanal 990 ㎕에 식물추출액 10 ㎕를 첨가하여 1/100로 희석한 후 0.3 mM DPPH ethanal solution을 사용하여 실온에서 30 min 반응 후 518 nm에서 흡광도를 측정하고 다음의 식을 이용 항산화활성을 측정하였다. Antioxidant activity was determined by DPPH photometric assay. After diluting 1/100 by adding 10 μl of plant extract to 990 μl of ethanal, the absorbance was measured at 518 nm after 30 min reaction at room temperature using 0.3 mM DPPH ethanal solution, and antioxidant activity was measured using the following equation.
항산화 활성 % = 100-[(샘플의 흡광도 - 브랭크의 흡광도) x 100/ 대조군의 흡광도]Antioxidant activity% = 100-[(absorbance of sample minus absorbance of blank) x 100 / absorbance of control]
상기의 실시예의 결과는 다음과 같다.The result of the above Example is as follows.
열대에서 자생하는 식물 8종에 대한 용매별 추출 분획의 항균활성을 평가한 결과 Piper sarmentosum Roxb(Wild Betal), Citrus aurantifolia swingle leaf(Lime leaf), Curcuma domestica Valeton(Turmeric), Sesbania grandiflora L.(Agati sesbania) 그리고 Citrus aurantifolia swingle(Lime)에서 항균활성이 검출되었고 특히 Citrus aurantifolia swingle(Lime)에서 매우 우수한 항균활성이 검출되었다. 그러나 Morinda citrifolia L. leaf(Beach mulberry leaf), Cassia siamea britt(Siamea Cassia) 그리고 Cocos nucifera L.(Coconut)에서는 다양한 용매에서 추출하였음에도 불구하고 항균활성이 관찰되지 않았다(표 3).The evaluation of the antimicrobial activity of the extracted fraction-specific solvent for the plant 8 grows in tropical species Piper sarmentosum Roxb (Wild Betal), Citrus aurantifolia swingle leaf (Lime leaf), Curcuma domestica Valeton (Turmeric), Sesbania grandiflora L. (Agati sesbania) and Citrus Antimicrobial activity was detected in aurantifolia swingle (Lime), especially Citrus Very good antimicrobial activity was detected in aurantifolia swingle (Lime). But Morinda citrifolia L. leaf (Beach mulberry leaf), Cassia siamea britt (Siamea Cassia) and Cocos nucifera In L. (Coconut), despite the extraction in various solvents, no antimicrobial activity was observed (Table 3).
표 3은 병원성 세균에 대한 열대식물의 용매 추출물의 항균활성을 나타낸 표로 1용매 분획: A. 물; B. 메탄올; C. 헥산; D. 클로로포름; E. 에틸 아세테이트 F. 부탄올을 나타내고, 항균 활성: -, no inhibition (8mm); +, very slight inhibition (9mm~11mm); ++, moderate inhibition (11mm~13mm); +++, heavy inhibition (13~17mm)으로 나타내었다. Table 3 shows the antimicrobial activity of the solvent extracts of tropical plants against pathogenic bacteria. 1 solvent fraction: A. water; B. methanol; C. hexane; D. chloroform; E. ethyl acetate F. butanol and antibacterial activity:-, no inhibition (8 mm); +, very slight inhibition (9mm ~ 11mm); ++, moderate inhibition (11mm ~ 13mm); +++, heavy inhibition (13 ~ 17mm) was shown.
1. 추출물과 용매별 1. Extracts and Solvents 분획물의Fraction 항균력 Antimicrobial activity
비교적 단단한 wax 층의 엽을 가진 향료 식물인 Citrus aurantifolia swingle leaf(Lime leaf)의 용매 추출 분획 중 methanol, n-hexane, Chloroform 분획에서 항균활성을 나타내었다. 그러나 각 항균활성 추출분획은 호흡기 질병의 원인균인 Burkholderia sp .과 Haemopillus somnus에 대하여 특이적인 항균활성을 나타내었고 다른 병원성 세균에 대하여서는 항균활성을 나타내지 않았다. Citrus , a fragrant plant with a relatively hard waxy layer of leaves Antibacterial activity was shown in methanol, n-hexane and chloroform fractions in solvent extraction fraction of aurantifolia swingle leaf (Lime leaf). However, each antimicrobial activity fraction Burkholderia , the causative agent of respiratory diseases, sp . And Haemopillus It showed specific antimicrobial activity against somnus and no antimicrobial activity against other pathogenic bacteria.
넓은 엽의 특성을 보이는 Piper sarmentosum Roxb(Wild Betal)에 대하여 다양한 용매로 추출한 분획의 항균력을 평가한 결과 methanol 추출물에서 미약한 항균활성이 검출되었고 착즙 및 기타 다른 용매에서는 항균활성이 검출되지 않았다. 특히 돼지 글래서병의 원인 균인 Haemopillus parasuis 대한 항균활성이 우수하였다. Piper showing broad lobe characteristics sarmentosum As a result of evaluating the antimicrobial activity of the fractions extracted with various solvents against Roxb (Wild Betal), weak antimicrobial activity was detected in methanol extract and no antimicrobial activity was detected in juice and other solvents. Haemopillus, the causative agent of swine glacier disease The antibacterial activity against parasuis was excellent.
근채류에 속하는 Curcuma domestica Valeton(Turmeric)은 Ethylacetate 분획에서 미약한 항균활성을 나타내었고 다른 용매 분획에서는 항균활성을 보이지 않았다. 그러나 가축의 장독혈증을 일으키는 Clostridium perfringens Type E 균주에 대하여서만 특이적인 항균활성을 나타내었고 항균활성 정도도 매우 우수하였다. Curcuma belonging to the root vegetable domestica Valeton (Turmeric) showed weak antimicrobial activity in the Ethylacetate fraction and no other antimicrobial activity in the other solvent fractions. But Clostridium causes livestock intestinalemia Specific antimicrobial activity was shown only against perfringens Type E strains and the degree of antimicrobial activity was very good.
Sesbania grandiflora L.(Agati sesbania) 추출 분획은 Burkholderia sp에 대하여서만 항균활성을 나타내었다. 그러나 매우 미약한 활성만을 나타내었다. Sesbania grandiflora L. (Agati sesbania) extract fraction is Burkholderia It showed antimicrobial activity only against sp . However, only very weak activity was shown.
과실류에 속하는 Citrus aurantifolia swingle(Lime)는 다른 식물 및 추출분획에 비하여 매우 넓은 항균활성 스팩트럼을 나타내었으며, 항균활성 정도도 매우 우수하였다. 특히 열수 추출한 분획은 Haemopillus somnus에 대하여 높은 항균활성을 보였으며, methanol 추출 분획은 다양한 병원균에 대하여 높은 항균활성을 나타내었다. 그러나 가축의 장독혈증을 유발하는 Clostridium perfringens Type E에 대하여서는 항균활성을 나타내지 않았다. 그 외 Morinda citrifola L. leaf, Cassia siamea britt 그리고 Cocos mucifera L.의 모든 추출분획들에서는 항균활성이 나타나지 않았다. Citrus belonging to the fruit The aurantifolia swingle (Lime) showed a much broader antimicrobial activity spectrum than the other plants and extract fractions. In particular, the fraction extracted by hot water is Haemopillus It showed high antimicrobial activity against somnus , and methanol extract fraction showed high antimicrobial activity against various pathogens. However, Clostridium causes livestock intestinalemia Perfringens Type E did not show antimicrobial activity. Other Morinda citrifola L. leaf, Cassia siamea britt and Cocos All extract fractions of mucifera L. did not show antimicrobial activity.
2. 식물 추출물 분획의 최소저해농도(2. Minimum inhibitory concentrations of plant extract fractions ( MICMIC ) 평가 ) evaluation
항균활성이 확인된 물질들을 대상으로 MIC (minimum inhibition concentration)를 조사한 결과 Sesbania grandiflora L(Agati sesbania, BaiKhae)의 buthanol 추출물에서 호흡기 병원균인 Burkholderia sp에 대한 MIC 농도가 135 ㎍/㎖로 가장 강한 항균 활성을 나타내었다 (표 4). Sesbania was tested on the MIC (minimum inhibition concentration) of the substances with antimicrobial activity. of grandiflora L (Agati sesbania, BaiKhae) Burkholderia , a respiratory pathogen, from buthanol extract for sp MIC concentration of 135 μg / ml It showed the strongest antimicrobial activity (Table 4).
agglomeransagglomerans
E. coli Enterotoxigenic
E. coli
spsp
..
somnussomnus
parsuisparsuis
perfringensperfringens
표 4는 미생물에 대한 열대 식물의 분획 및 추출물의 최소 저해 농도(Minimum inhibitory concentration)를 나타내고, 표에서 ND : not detected를 나타낸다.Table 4 shows the minimum inhibitory concentrations of the fractions and extracts of tropical plants against microorganisms, and ND: not detected in the table.
3. 식물 추출물 분획의 항산화활성 평가3. Evaluation of Antioxidant Activity of Plant Extract Fractions
대부분의 식물에서 비교적 높은 항산화 활성을 나타내었고, 특히 Citrus aurantifolia swingle(Lime), Citrus aurantifolia swingle leaf(Lime leaf), Morinda citrifolia L. leaf(Beach mulberry leaf), Curcuma domestica Valeton(Turmeric), Cassia siamea britt(Siamea Cassia) 등에서 methnol 추출물이 높은 활성을 나타내었다 (표 5).Most plants showed relatively high antioxidant activity, especially Citrus aurantifolia swingle (Lime), Citrus aurantifolia swingle leaf (Lime leaf), Morinda citrifolia L. leaf (Beach mulberry leaf), Curcuma domestica Valeton (Turmeric), Cassia siamea britt (Siamea Cassia) Methnol extract showed high activity in the back (Table 5).
표 5는 열대 식물의 용매 추출물의 항산화활성을 나타낸다
Table 5 shows the antioxidant activity of the solvent extracts of tropical plants
Claims (8)
Burkholderia sp, or Haemophilus somnus, comprising an extract of any one of methanol, hexane, and chloroform extracts of Citrus aurantifolia swingle leaf (Lime leaf) as an active ingredient. Antibiotic pharmaceutical composition for Haemopillus somnus).
Burkholderia sp, or Haemophilus somnus, comprising an extract of any one of methanol, hexane, and chloroform extracts of Citrus aurantifolia swingle leaf (Lime leaf) as an active ingredient. Feed composition having an antibiotic effect on Haemopillus somnus).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110015226A KR101106053B1 (en) | 2011-02-21 | 2011-02-21 | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110015226A KR101106053B1 (en) | 2011-02-21 | 2011-02-21 | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080111792A Division KR101106052B1 (en) | 2008-11-11 | 2008-11-11 | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110027734A KR20110027734A (en) | 2011-03-16 |
KR101106053B1 true KR101106053B1 (en) | 2012-01-18 |
Family
ID=43934379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110015226A KR101106053B1 (en) | 2011-02-21 | 2011-02-21 | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101106053B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103860680A (en) * | 2014-03-17 | 2014-06-18 | 安徽科技学院 | Medicine for preventing and treating haemophilus parasuis |
-
2011
- 2011-02-21 KR KR1020110015226A patent/KR101106053B1/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
Sumonrat Chanthaphon외, Songklanakarin J. Sci. Technol.30 (Suppl.1), 2008년 4월, p125-131 |
Also Published As
Publication number | Publication date |
---|---|
KR20110027734A (en) | 2011-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alagawany et al. | Paenibacillus polymyxa (LM31) as a new feed additive: Antioxidant and antimicrobial activity and its effects on growth, blood biochemistry, and intestinal bacterial populations of growing Japanese quail | |
DE69934141T2 (en) | MICROORGANISM AND APPLICATION THEREOF | |
Akhtar et al. | In vitro antibacterial activity of Pimpinella anisum fruit extracts against some pathogenic bacteria | |
KR20120107557A (en) | Rice bran fermentation extracts with chlorophyll and the manufacturing method thereof | |
Abd El-Hack et al. | Pharmacological, nutritional and antimicrobial uses of Moringa oleifera Lam. leaves in poultry nutrition: an updated knowledge | |
CN109674778B (en) | Lipid antibacterial composition, extraction method, detection method and application | |
JP4932737B2 (en) | Composition for spore sterilization of spore-type microorganism containing extract of serpentine | |
Tajbakhsh et al. | In vitro study of antibacterial activity of the alga Sargassum oligocystum from the Persian Gulf | |
EP2668849A1 (en) | Feed additive of plant origin | |
CN114208948A (en) | Liposome for feed additive and preparation method thereof | |
KR101106056B1 (en) | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof | |
KR101982813B1 (en) | The manufactured method of natural fermented feed for immunity buildup | |
KR101106055B1 (en) | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof | |
JP5943406B2 (en) | Composition for maintaining the survival of bifidobacteria or lactic acid bacteria | |
Jabri et al. | Effect of Olive leaves extract supplementation in drinking water on zootechnical performances and cecal microbiota balance of broiler chickens | |
KR101106053B1 (en) | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof | |
KR102315313B1 (en) | Pet food supplement for improving immunity and removing odor, and manufacturing method thereof | |
Selvaraj et al. | Effect of probiotic supplemented feed on growth performance of molly fish (Poecilia sphenops) in recirculating aquaculture system | |
Ahmad et al. | Effects of replacing antibiotic growth promoters (AGPS) with botanical extracts and oils in feed of laying hens on production, performance and some microbial counts in feces. | |
KR101106054B1 (en) | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof | |
KR101890877B1 (en) | supplementary feed for fish farming and manufacturing method thereof | |
KR101106052B1 (en) | Antimicrobial composition for pathogenic microorganism comprising plant or extract thereof | |
CN114177232A (en) | Extraction method of tea polyphenol extract, extracted tea polyphenol extract and application thereof | |
KR101750111B1 (en) | Compositions for immune enhancement comprising oil mixture | |
RU2779648C2 (en) | Method for obtaining a biologically active feed additive for farm animals and poultry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20150706 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160115 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |